Animal IVD Market Trends and Forecast
The future of the global animal IVD market looks promising with opportunities in the pet hospital, animal husbandry & veterinary system, zoo, research institute animal experiment center, and animal & plant quarantine department markets. The global animal IVD market is expected to grow with a CAGR of 7.5% from 2026 to 2035. The major drivers for this market are the increasing demand for animal health diagnostics, the rising prevalence of zoonotic & infectious diseases, and the growing adoption of point of care testing.
• Lucintel forecasts that, within the type category, immunodiagnosis is expected to witness higher growth over the forecast period.
• Within the application category, animal husbandry & veterinary system is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.
Emerging Trends in the Animal IVD Market
The animal IVD market is experiencing rapid growth driven by technological advancements, increasing pet ownership, and a rising focus on animal health. As the veterinary sector adopts innovative diagnostic tools, the market is becoming more dynamic and competitive. These developments are transforming how veterinarians diagnose and treat animal diseases, leading to improved health outcomes and more efficient clinical practices. The integration of new technologies and expanding applications are also opening new opportunities for market players. Understanding these emerging trends is essential for stakeholders aiming to capitalize on the evolving landscape and meet the growing demand for advanced veterinary diagnostics.
• Technological Innovations in Diagnostic Tools: The market is witnessing significant advancements in diagnostic technologies such as molecular diagnostics, point-of-care testing, and digital imaging. These innovations enable faster, more accurate detection of diseases, improving clinical decision-making. Portable and user-friendly devices are increasingly being adopted in veterinary clinics, enhancing accessibility and reducing turnaround times. The integration of artificial intelligence and machine learning further enhances diagnostic precision. These technological developments are driving market growth by expanding the range of detectable conditions and improving diagnostic workflows, ultimately leading to better health management for animals.
• Rising Pet Ownership and Humanization of Pets: Increasing pet ownership worldwide, especially in urban areas, is fueling demand for advanced veterinary diagnostics. Pet owners are now more invested in their animals health, seeking comprehensive health assessments and early disease detection. The trend toward humanization of pets has led to higher spending on veterinary care, including diagnostics. This shift is encouraging veterinary clinics to adopt sophisticated diagnostic tools to meet client expectations. As a result, the market is expanding, with more products tailored to the needs of pet owners who view their animals as family members, thereby boosting demand for IVD solutions.
• Growing Prevalence of Animal Diseases: The rising incidence of infectious and chronic diseases in animals is a key driver for the market. Conditions such as parasitic infections, zoonoses, and metabolic disorders require accurate and timely diagnosis for effective treatment. The increasing prevalence of these diseases, coupled with the need for disease surveillance and control, is prompting veterinary clinics and laboratories to invest in advanced diagnostic solutions. This trend is particularly prominent in regions with dense livestock populations and high pet ownership. The demand for reliable diagnostic tests to manage and prevent disease outbreaks is significantly contributing to market expansion.
• Regulatory Developments and Standardization: Evolving regulatory frameworks and increased emphasis on quality standards are shaping the market landscape. Governments and regulatory bodies are implementing stricter guidelines for veterinary diagnostics to ensure safety, efficacy, and reliability. This has led to increased investment in research and development, as well as the approval of new diagnostic products. Standardization efforts are also facilitating global trade and market entry for innovative solutions. These regulatory developments are fostering a more trustworthy and competitive market environment, encouraging manufacturers to develop high-quality, compliant products that meet international standards.
• Expansion of Point-of-Care Testing (POCT): The adoption of point-of-care testing is revolutionizing veterinary diagnostics by enabling rapid, on-site disease detection. POCT devices are portable, easy to use, and provide immediate results, which is crucial in emergency situations and remote locations. This trend is particularly impactful in livestock management, where quick decision-making can prevent disease spread. The convenience and speed of POCT are also improving client satisfaction and operational efficiency in veterinary practices. As technology advances and costs decrease, POCT is expected to become a standard component of veterinary diagnostics, significantly expanding market reach and application scope.
These emerging trends are collectively reshaping the animal IVD market by enhancing diagnostic accuracy, expanding accessibility, and improving disease management. Technological innovations, changing consumer behaviors, disease prevalence, regulatory support, and the rise of point-of-care testing are driving growth and transforming the landscape. These developments are enabling more proactive, efficient, and precise veterinary care, ultimately benefiting animal health and welfare while opening new avenues for market expansion.
Recent Development in the Animal IVD Market
The animal IVD market is experiencing rapid growth driven by technological advancements, increasing pet ownership, and a rising focus on animal health. Innovations in diagnostic tools are enabling quicker, more accurate disease detection, which improves treatment outcomes. The expanding market presents significant opportunities for manufacturers and service providers. As awareness about zoonotic diseases grows, demand for reliable diagnostic solutions is surging. This evolving landscape is reshaping how veterinary care is delivered, emphasizing early diagnosis and personalized treatment approaches.
• Technological Innovations in Diagnostic Tools: The development of advanced, rapid, and accurate diagnostic devices is transforming animal healthcare. These innovations enable veterinarians to detect diseases early, improving treatment success rates. Portable and user-friendly devices facilitate on-site testing, reducing turnaround times and costs. As technology continues to evolve, the market is expected to see increased adoption of molecular diagnostics, digital imaging, and AI-powered tools, ultimately enhancing diagnostic precision and expanding market reach.
• Rising Pet Ownership and Humanization of Pets: The increasing number of pet owners worldwide is driving demand for comprehensive veterinary diagnostics. Pet owners are investing more in their animals health, seeking early and accurate diagnoses. This trend is particularly prominent in urban areas, where pets are considered family members. The humanization trend encourages pet owners to opt for advanced diagnostic services, boosting market growth. Veterinary clinics and diagnostic labs are expanding their offerings to meet this rising demand, fostering market expansion.
• Growing Prevalence of Zoonotic and Chronic Diseases: The rise in zoonotic diseases and chronic conditions among animals is fueling the need for reliable diagnostic solutions. Early detection of diseases like Lyme disease, parvovirus, and heartworm is critical for effective treatment. The market is responding with targeted tests and panels that improve disease management. Increased awareness among pet owners and veterinarians about these health issues is further propelling demand, leading to innovations in diagnostic assays and expanding the market scope.
• Regulatory Support and Increased Investment: Governments and regulatory bodies are promoting animal health through supportive policies and funding. Investments in research and development are fostering innovation in diagnostic technologies. Regulatory approvals streamline market entry for new products, encouraging companies to develop novel solutions. Public-private partnerships and grants are also enhancing market growth prospects. This supportive environment is attracting new entrants and accelerating the adoption of advanced diagnostics, thereby expanding the overall market size.
• Expansion of Veterinary Diagnostic Laboratories and Services: The proliferation of veterinary diagnostic labs and specialized services is increasing accessibility to advanced testing. These facilities are adopting cutting-edge technologies to offer comprehensive diagnostic panels. The expansion is driven by rising demand from veterinary clinics, pet owners, and livestock sectors. Enhanced laboratory infrastructure improves diagnostic turnaround times and accuracy, fostering trust and repeat business. This growth in diagnostic services is crucial for early disease detection, treatment planning, and overall market development.
The overall impact of these developments is a robust, innovative, and expanding animal IVD market. Enhanced diagnostic capabilities are improving animal health outcomes, increasing market competitiveness, and fostering new business opportunities. The markets growth is also contributing to better disease management, reduced treatment costs, and increased awareness about animal health, ultimately benefiting veterinarians, pet owners, and the industry at large.
Strategic Growth Opportunities in the Animal IVD Market
The animal IVD market is experiencing rapid expansion driven by increasing pet ownership, advancements in diagnostic technologies, and rising awareness of animal health. The demand for accurate, rapid, and cost-effective diagnostic solutions is fueling innovation and market growth. Key applications such as disease detection, wellness screening, and personalized veterinary care are creating new opportunities. Strategic investments and collaborations are further accelerating market development, making it a promising sector for stakeholders aiming to improve animal health outcomes and expand their market presence.
• Growing Demand For Rapid And Accurate Diagnostic Tests: The increasing need for quick, reliable diagnostic tools in veterinary medicine is a major growth driver. Advances in point-of-care testing and molecular diagnostics enable early disease detection, improving treatment outcomes. Rising pet ownership and awareness of zoonotic diseases also contribute to this demand. Companies are investing in innovative technologies to meet these needs, expanding the market for animal IVD products and services.
• Expansion Of Companion Animal Diagnostics Market: The rising number of pet owners worldwide is fueling demand for diagnostic solutions tailored to companion animals. Owners seek comprehensive health assessments, disease screening, and preventive care. Veterinary clinics are adopting advanced IVD tools to improve diagnostics, leading to increased sales and product development. This expansion is supported by increased awareness of pet health and the need for early intervention, creating significant growth opportunities.
• Increasing Adoption Of Molecular Diagnostic Techniques: Molecular diagnostics offer high sensitivity and specificity for detecting infectious diseases, genetic disorders, and cancers in animals. The adoption of PCR, next-generation sequencing, and other molecular methods is rising due to their accuracy and speed. Veterinary laboratories and clinics are integrating these techniques into routine diagnostics, which enhances disease management and control. This trend is expected to continue, driving innovation and market growth.
• Rising Focus On Personalized Veterinary Medicine: Personalized medicine in veterinary care involves tailoring treatments based on genetic, biochemical, and diagnostic data. The use of IVD tools to identify specific biomarkers enables targeted therapies, improving efficacy and reducing side effects. This approach is gaining traction among veterinary practitioners and pet owners seeking advanced care options. The development of companion diagnostics and precision medicine is opening new revenue streams and expanding the scope of animal IVD applications.
• Increasing Investment In Veterinary Diagnostic Startups And Collaborations: Venture capital and corporate investments are fueling innovation in the animal IVD sector. Startups are developing novel diagnostic platforms, while collaborations between biotech firms and veterinary clinics accelerate product commercialization. These investments support research, regulatory approvals, and market expansion efforts. As a result, the industry is witnessing rapid technological advancements and increased market competitiveness, which will further drive growth and adoption of advanced diagnostic solutions.
The overall impact of these opportunities is a robust, innovative, and expanding animal IVD market. Stakeholders can capitalize on technological advancements, rising pet health awareness, and strategic collaborations to enhance market share. This growth will improve diagnostic accuracy, enable personalized treatments, and ultimately lead to better health outcomes for animals, fostering long-term industry sustainability and profitability.
Animal IVD Market Driver and Challenges
The animal IVD market is influenced by a complex interplay of technological advancements, economic factors, and regulatory frameworks. Rapid innovations in diagnostic technologies, increasing adoption of point-of-care testing, and rising demand for early disease detection are key drivers propelling market growth. Economic factors such as rising animal healthcare expenditure and increasing prevalence of animal diseases further stimulate market expansion. Additionally, stringent regulatory standards and the need for accurate, rapid diagnostics pose both opportunities and challenges. Understanding these drivers and challenges is essential for stakeholders aiming to capitalize on market potential while navigating regulatory and technological hurdles.
The factors responsible for driving the animal IVD market include:
• Technological Innovation: The development of advanced diagnostic tools such as multiplex assays, molecular diagnostics, and portable testing devices significantly enhances the accuracy, speed, and ease of animal disease detection. These innovations enable early diagnosis, improving treatment outcomes and reducing economic losses for farmers and pet owners. Continuous R&D investments foster the creation of more sensitive and specific tests, expanding market opportunities. Moreover, integration with digital health platforms allows for real-time data sharing and remote monitoring, further boosting adoption rates. As technology evolves, the market is expected to see increased demand for user-friendly, cost-effective diagnostic solutions, driving overall growth.
• Rising Prevalence of Animal Diseases: The increasing incidence of infectious and chronic diseases in animals, such as avian influenza, foot-and-mouth disease, and parasitic infections, necessitates reliable diagnostic tools. The growing awareness among pet owners and livestock farmers about disease management and prevention fuels demand for accurate testing. Governments and veterinary organizations are emphasizing disease control programs, which require efficient diagnostic solutions. This trend not only supports the expansion of diagnostic testing but also encourages the development of targeted tests for emerging diseases. Consequently, the rising disease burden directly correlates with increased market demand for comprehensive IVD solutions.
• Growing Pet Ownership and Companion Animal Care: The surge in pet ownership globally, especially in developed countries, has led to increased expenditure on pet healthcare. Owners are more proactive about regular health check-ups and disease screening, which drives demand for veterinary diagnostic tests. The rising awareness about zoonotic diseases and the importance of early detection further amplifies this trend. Veterinary clinics and hospitals are adopting advanced diagnostic tools to provide better care, creating a robust market for IVD products. This demographic shift towards responsible pet ownership is a significant factor fueling market growth, with an emphasis on non-invasive, rapid, and accurate testing methods.
• Increasing Investment and Strategic Collaborations: The market benefits from substantial investments by pharmaceutical companies, biotech firms, and venture capitalists aiming to develop innovative diagnostic solutions. Strategic collaborations between diagnostic companies and veterinary healthcare providers facilitate product development, commercialization, and distribution. These partnerships enable access to new markets and foster technological advancements. Additionally, government grants and funding initiatives support research activities, accelerating innovation. The influx of capital and strategic alliances enhances product pipelines and market reach, ultimately driving growth and competitiveness within the Animal IVD sector.
• Regulatory Developments and Market Expansion: Evolving regulatory standards aimed at ensuring the safety, efficacy, and quality of diagnostic products influence market dynamics. Stringent approval processes can pose challenges but also ensure high-quality offerings, boosting consumer confidence. Regulatory harmonization across regions facilitates international trade and market expansion. Governments are implementing policies to promote veterinary diagnostics, including subsidies and incentives, which encourage adoption. Compliance with regulatory requirements also spurs innovation, leading to the development of more reliable and standardized tests. Overall, regulatory frameworks shape market growth by balancing innovation with safety and quality assurance.
The challenges facing the animal IVD market include:
• High Cost of Advanced Diagnostic Technologies: The adoption of sophisticated diagnostic tools often involves significant investment in equipment, reagents, and training. Small veterinary clinics and livestock farmers may find these costs prohibitive, limiting market penetration in developing regions. Additionally, the high cost can impact the affordability of tests for end-users, reducing accessibility and slowing adoption rates. Manufacturers face the challenge of balancing technological sophistication with cost-effectiveness to expand their customer base. Overcoming this barrier requires innovation in manufacturing processes and strategic pricing models to make advanced diagnostics more accessible across diverse economic settings.
• Regulatory Complexity and Approval Delays: Navigating the complex regulatory landscape for veterinary diagnostics can be time-consuming and costly. Different regions have varying standards and approval procedures, which can delay product launches and increase compliance costs. Lengthy approval timelines may hinder rapid market entry for innovative products, affecting competitiveness. Moreover, evolving regulations require continuous updates and re-evaluation of existing products, adding to operational challenges. Companies must invest in regulatory expertise and adapt to changing standards to ensure timely approval, which can be resource-intensive and impact overall market growth.
• Limited Awareness and Accessibility in Emerging Markets: Despite growth potential, many developing regions face challenges related to awareness, infrastructure, and access to veterinary diagnostic services. Lack of trained personnel and inadequate healthcare infrastructure hinder the effective deployment of IVD solutions. Additionally, limited awareness among farmers and pet owners about the benefits of early diagnosis restricts demand. Addressing these issues requires targeted educational campaigns, capacity building, and infrastructure development. Without these efforts, market expansion in emerging economies may remain constrained, limiting the global reach of advanced veterinary diagnostics.
The animal IVD market is driven by technological innovations, rising disease prevalence, increasing pet ownership, strategic investments, and supportive regulatory developments. However, high costs, regulatory hurdles, and limited awareness in emerging markets pose significant challenges. These factors collectively influence the pace and scope of market growth. While technological advancements and regulatory support foster expansion, economic barriers and awareness gaps may slow progress in certain regions. Overall, the markets future depends on balancing innovation with affordability and accessibility, ensuring sustainable growth and improved animal health worldwide.
List of Animal IVD Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies animal IVD companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the animal IVD companies profiled in this report include-
• Heska
• Zoetis
• Antech
• Eurofins Ingenasa
• IDEXX
• Bio-Rad
• Thermo Fisher Scientific
• Randox
• Idvet
• Edan Instruments
Animal IVD Market by Segment
The study includes a forecast for the global animal IVD market by type, application, and region.
Animal IVD Market by Type [Value from 2019 to 2035]:
• Immunodiagnosis
• Clinical Biochemistry & Molecular Diagnosis
• Hematology
• Others
Animal IVD Market by Application [Value from 2019 to 2035]:
• Pet Hospital
• Animal Husbandry & Veterinary System
• Zoo
• Research Institute Animal Experiment Center
• Animal & Plant Quarantine Department
• Others
Animal IVD Market by Region [Value from 2019 to 2035]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Animal IVD Market
The animal IVD market has experienced significant growth driven by advancements in veterinary medicine, increasing pet ownership, and the need for early disease detection in animals. Technological innovations, regulatory approvals, and expanding applications in disease management are shaping the landscape across major markets. The United States, China, Germany, India, and Japan are key players, each contributing unique developments that influence global trends. These countries are investing in research, expanding product portfolios, and adopting new diagnostic technologies to improve animal health outcomes and meet rising demand for veterinary diagnostics.
• United States: The US animal IVD market is rapidly expanding due to increased pet ownership and a focus on early disease detection. Innovations in molecular diagnostics and point-of-care testing are gaining traction. Regulatory agencies like the FDA are streamlining approval processes, encouraging new product launches. Companies are investing heavily in R&D to develop advanced diagnostic tools for infectious diseases, cancer, and genetic disorders in animals. The market also benefits from a well-established veterinary healthcare infrastructure and rising awareness among pet owners about animal health. Telemedicine integration is further enhancing diagnostic accessibility and efficiency.
• China: China’s animal IVD market is witnessing robust growth driven by rising disposable incomes and increasing pet adoption. The government’s focus on animal health and welfare has led to supportive policies and investments in veterinary infrastructure. Local companies are expanding their product offerings, including rapid diagnostic kits and molecular testing solutions. The adoption of advanced technologies such as PCR and ELISA is increasing, especially in urban centers. Additionally, the growing prevalence of zoonotic diseases has spurred demand for reliable diagnostic tools. Collaborations with international firms are facilitating technology transfer and innovation, positioning China as a key emerging market.
• Germany: Germany remains a leader in the European animal IVD market, characterized by high veterinary healthcare standards and technological innovation. The market is driven by a strong emphasis on disease prevention and health management in companion animals and livestock. Companies are focusing on developing sensitive, rapid, and user-friendly diagnostic tests. Regulatory frameworks in the EU ensure product safety and efficacy, fostering trust among users. Germany’s integration of digital health solutions and laboratory automation is enhancing diagnostic accuracy and workflow efficiency. The country also emphasizes sustainable and eco-friendly diagnostic products, aligning with broader environmental goals.
• India: The Indian animal IVD market is experiencing rapid growth due to increasing awareness of animal health and rising pet ownership. The expanding livestock sector is also a significant driver, with a focus on disease control and productivity enhancement. Local manufacturers are introducing affordable diagnostic kits tailored to regional needs, including tests for prevalent zoonotic diseases. The government’s initiatives to improve veterinary healthcare infrastructure and disease surveillance are boosting market prospects. Technological adoption, such as portable and rapid testing devices, is increasing in rural and semi-urban areas. Collaborations with global firms are helping to introduce innovative diagnostic solutions to the Indian market.
• Japan: Japan’s animal IVD market is characterized by high technological adoption and a focus on advanced diagnostics for companion animals and livestock. The aging pet population has increased demand for health monitoring and disease management solutions. Japan’s stringent regulatory environment ensures high-quality standards for diagnostic products. Companies are investing in research to develop personalized veterinary diagnostics and molecular testing methods. The integration of AI and data analytics is improving diagnostic accuracy and treatment planning. Japan also emphasizes sustainable and environmentally friendly diagnostic products, aligning with its broader environmental policies. The market continues to evolve with innovations in digital health and telemedicine for veterinary care.
Features of the Global Animal IVD Market
Market Size Estimates: Animal IVD market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
Segmentation Analysis: Animal IVD market size by type, application, and region in terms of value ($B).
Regional Analysis: Animal IVD market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the animal IVD market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the animal IVD market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for animal IVD market?
Answer: The global animal IVD market is expected to grow with a CAGR of 7.5% from 2026 to 2035.
Q2. What are the major drivers influencing the growth of the animal IVD market?
Answer: The major drivers for this market are the increasing demand for animal health diagnostics, the rising prevalence of zoonotic & infectious diseases, and the growing adoption of point of care testing.
Q3. What are the major segments for animal IVD market?
Answer: The future of the animal IVD market looks promising with opportunities in the pet hospital, animal husbandry & veterinary system, zoo, research institute animal experiment center, and animal & plant quarantine department markets.
Q4. Who are the key animal IVD market companies?
Answer: Some of the key animal IVD companies are as follows:
• Heska
• Zoetis
• Antech
• Eurofins Ingenasa
• IDEXX
• Bio-Rad
• Thermo Fisher Scientific
• Randox
• Idvet
• Edan Instruments
Q5. Which animal IVD market segment will be the largest in future?
Answer: Lucintel forecasts that, within the type category, immunodiagnosis is expected to witness higher growth over the forecast period.
Q6. In animal IVD market, which region is expected to be the largest in next 5 years?
Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the animal IVD market by type (immunodiagnosis, clinical biochemistry & molecular diagnosis, hematology, and others), application (pet hospital, animal husbandry & veterinary system, zoo, research institute animal experiment center, animal & plant quarantine department, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?
For any questions related to Animal IVD Market, Animal IVD Market Size, Animal IVD Market Growth, Animal IVD Market Analysis, Animal IVD Market Report, Animal IVD Market Share, Animal IVD Market Trends, Animal IVD Market Forecast, Animal IVD Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.